Neurocrine Biosciences, Inc.NBIXNASDAQ
LOADING
|||
Switch Symbol:
Revenue Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
15.62%
↓ 42% below average
Average (39q)
26.77%
Historical baseline
Range
High:859.34%
Low:-100.00%
Volatility
3583.2%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 15.62% |
| Q2 2025 | 20.07% |
| Q1 2025 | -8.78% |
| Q4 2024 | 0.90% |
| Q3 2024 | 5.40% |
| Q2 2024 | 14.54% |
| Q1 2024 | 0.02% |
| Q4 2023 | 3.29% |
| Q3 2023 | 10.18% |
| Q2 2023 | 7.68% |
| Q1 2023 | 2.04% |
| Q4 2022 | 6.21% |
| Q3 2022 | 2.56% |
| Q2 2022 | 21.76% |
| Q1 2022 | -0.45% |
| Q4 2021 | 5.41% |
| Q3 2021 | 2.46% |
| Q2 2021 | 22.10% |
| Q1 2021 | -4.56% |
| Q4 2020 | -4.10% |
| Q3 2020 | -14.52% |
| Q2 2020 | 27.54% |
| Q1 2020 | -2.83% |
| Q4 2019 | 9.86% |
| Q3 2019 | 21.04% |
| Q2 2019 | 32.59% |
| Q1 2019 | 5.25% |
| Q4 2018 | -13.35% |
| Q3 2018 | 56.60% |
| Q2 2018 | 36.32% |
| Q1 2018 | -24.79% |
| Q4 2017 | 55.52% |
| Q3 2017 | 859.34% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | -100.00% |
| Q1 2016 | 0.00% |
| Q4 2015 | 0.00% |